F-star Therapeutics, Inc.
FSTX · NASDAQ
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $36 | $53 | $69 | $79 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $8 | $7 | $4 | $2 |
| Inventory | $0 | $0 | $0 | -$2 |
| Other Curr. Assets | $6 | $5 | $4 | $6 |
| Total Curr. Assets | $50 | $65 | $77 | $85 |
| Property Plant & Equip (Net) | $3 | $4 | $4 | $4 |
| Goodwill | $14 | $14 | $15 | $15 |
| Intangibles | $16 | $17 | $18 | $19 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $34 | $36 | $37 | $38 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $84 | $101 | $115 | $123 |
| Liabilities | – | – | – | – |
| Payables | $3 | $4 | $4 | $3 |
| Short-Term Debt | $2 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $6 |
| Other Curr. Liab. | $10 | $10 | $7 | $2 |
| Total Curr. Liab. | $15 | $15 | $13 | $12 |
| LT Debt | $11 | $12 | $12 | $12 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $2 | $2 | $2 | $2 |
| Total NC Liab. | $12 | $14 | $14 | $14 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $27 | $29 | $27 | $26 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$128 | -$110 | -$91 | -$78 |
| AOCI | $2 | -$1 | -$1 | -$2 |
| Other Equity | $183 | $182 | $180 | $177 |
| Total Equity | $57 | $72 | $88 | $97 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $84 | $101 | $115 | $123 |
| Net Debt | -$23 | -$40 | -$56 | -$65 |